|
Market Closed -
Bombay S.E.
03:32:19 20/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 2,530.40 INR | -1.58% |
|
+2.23% | +37.43% |
| 15/08 | Caplin Point Laboratories Limited, Q1 2027 Earnings Call, Aug 12, 2026 | |
| 12/08 | Caplin Point Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
Company Valuation: Caplin Point Laboratories Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 30,571 | 51,529 | 45,291 | 1,00,038 | 1,52,221 | 1,92,340 | - | - |
| Change | - | 68.55% | -12.11% | 120.88% | 52.16% | 26.36% | - | - |
| Enterprise Value (EV) | 30,571 | 51,529 | 45,291 | 1,00,038 | 1,52,221 | 1,92,340 | 1,92,340 | 1,92,340 |
| Change | - | 68.55% | -12.11% | 120.88% | 52.16% | 26.36% | 0% | 0% |
| P/E | 12.7x | 17.3x | 12.1x | 22x | 28.5x | 17.9x | 26.5x | 22.9x |
| PBR | 2.58x | 3.47x | 2.41x | 4.32x | 5.34x | 3.19x | 4.36x | 3.94x |
| PEG | - | 0.7x | 0.5x | 1x | 1.6x | 0.9x | 1.5x | 1.4x |
| Capitalization / Revenue | 2.88x | 4.06x | 3.09x | 5.91x | 7.86x | 5.23x | 7.67x | 6.79x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 9.04x | 7.67x | 6.79x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 0x | 25.9x | 22.1x | 19.1x |
| EV / EBIT | 0x | 0x | 0x | - | 0x | 24.7x | 20.6x | 17.9x |
| EV / FCF | 0x | 0x | 0x | 0x | 0x | 50.6x | 34.6x | 34.1x |
| FCF Yield | 6.39% | 4.77% | 1.72% | 1.73% | 1.58% | 2.4% | 2.89% | 2.93% |
| Dividend per Share 2 | 3 | 2 | 2 | 2.5 | 3 | - | 4 | 4 |
| Rate of return | 0.74% | 0.29% | 0.34% | 0.19% | 0.15% | - | 0.16% | 0.16% |
| EPS 2 | 31.71 | 39.26 | 49.18 | 59.9 | 70.25 | 84.11 | 95.6 | 110.7 |
| Distribution rate | 9.46% | 5.09% | 4.07% | 4.17% | 4.27% | - | 4.18% | 3.61% |
| Net sales 1 | 10,613 | 12,694 | 14,667 | 16,941 | 19,375 | 21,872 | 25,072 | 28,340 |
| EBITDA 1 | 3,286 | 3,947 | 4,411 | 5,514 | 6,469 | 7,609 | 8,700 | 10,050 |
| EBIT 1 | 3,152 | 3,478 | 4,520 | - | 5,810 | 8,036 | 9,321 | 10,752 |
| Net income 1 | 2,423 | 2,998 | 3,763 | 4,571 | 5,363 | 6,412 | 7,264 | 8,411 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 404.15 | 679.90 | 596.70 | 1,317.30 | 2,002.60 | 2,530.40 | 2,530.40 | 2,530.40 |
| Nbr of stocks (in thousands) | 75,643 | 75,789 | 75,903 | 75,942 | 76,012 | 76,012 | - | - |
| Announcement Date | 06/05/21 | 12/05/22 | 27/05/23 | 16/05/24 | 15/05/25 | 14/05/26 | - | - |
1INR in Million2INR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 31.7x | - | - | - | 204.46Cr | |
| 35.06x | 6.57x | 22.78x | 0.9% | 4.77TCr | |
| 18.39x | 2.19x | 9.92x | 1.41% | 4TCr | |
| 27.68x | 3.36x | 17.43x | 0.91% | 1.2TCr | |
| 26.48x | 3.79x | 15.72x | 0.61% | 1.15TCr | |
| 18.73x | 3.33x | 11.58x | 3.85% | 917.69Cr | |
| 9.03x | 2.08x | 5.42x | 4.46% | 753.14Cr | |
| 16.02x | 2.09x | 6.8x | 3.19% | 729.33Cr | |
| 27.32x | 3.56x | 16.55x | 0.17% | 663.27Cr | |
| Average | 23.38x | 3.37x | 13.27x | 1.94% | 1.6TCr | |
| Weighted average by Cap. | 25.35x | 4.02x | 15.37x | 1.48% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 524742 Stock
- Valuation Caplin Point Laboratories Limited
Select your edition
All financial news and data tailored to specific country editions
